Option Care Health, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Option Care Health reported Q2 2026 results with increased net revenue driven by its acute portfolio, though gross profit margin saw a slight decrease due to shifts in therapy mix.
NASDAQ
Option Care Health, Inc. reported increased net revenue for the third quarter and first nine months of 2025, driven by organic growth and an acquisition, alongside a significant debt refinancing and continued share repurchases.
NASDAQ
10-Q: Option Care Health Reports Strong Revenue Growth Amidst Margin Pressures and Strategic Acquisition
Option Care Health, Inc. announced robust revenue growth for the second quarter and first half of 2025, driven by organic expansion and a recent acquisition, though profitability margins experienced a decline.
NASDAQ
Option Care Health's Q1 2025 net revenue increased by 16.3% year-over-year, driven by organic growth in both acute and chronic therapies.
NASDAQ
10-Q: Option Care Health Reports Third Quarter 2024 Results, Revenue Growth Driven by Chronic Therapies
Option Care Health's third quarter 2024 results show a revenue increase driven by organic growth in chronic therapies, despite a slight decrease in gross profit margin.
NASDAQ
10-Q: Option Care Health Reports Second Quarter 2024 Results, Revenue Growth Driven by Chronic Therapies
Option Care Health's second quarter 2024 results show revenue growth driven by chronic therapies, despite a slight decrease in gross profit margin.
NASDAQ
Option Care Health's first quarter 2024 results show a 12.8% increase in net revenue compared to the same period last year, despite challenges from a cybersecurity incident.